NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-148-2003-0-PCT-02 Gene Expressed in Prostate Cancer, Methods and Use Thereof PCT PCT PCT/US2004/10588 Expired
NIAID E-165-2004-0-US-01 SARS Coronavirus MVA Vaccines And Therapy US 60/558,995 Abandoned
NICHD E-107-2003-0-AU-06 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. AU National Stage 2004228631 Abandoned
NICHD E-107-2003-0-BE-12 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. BE EP 04758715.9 Abandoned
NICHD E-107-2003-0-ES-15 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. ES EP 04758715.9 Abandoned
NICHD E-107-2003-0-EP-03 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. EP National Stage 04758715.9 Abandoned
NICHD E-107-2003-0-GB-17 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. GB EP 04758715.9 Abandoned
NICHD E-107-2003-0-CH-13 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. CH EP 04758715.9 Abandoned
NICHD E-107-2003-0-IE-18 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. IE EP 04758715.9 Abandoned
NICHD E-107-2003-0-IT-19 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. IT EP 04758715.9 Abandoned
NICHD E-107-2003-0-DE-14 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. DE EP 04758715.9 Abandoned
NICHD E-107-2003-0-FR-16 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. FR EP 04758715.9 Abandoned
NICHD E-107-2003-0-LI-20 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi.
1613641 		LI EP 04758715.9 Abandoned
NICHD E-107-2003-0-NL-21 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. NL EP 04758715.9 Abandoned
NICHD E-107-2003-0-PCT-02 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. PCT PCT PCT/US2004/10007 Expired
NICHD E-107-2003-0-CN-10 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. CN DIV 200710161290.8 Abandoned
NICHD E-107-2003-0-EP-11 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. EP DIV 08166066.4 Abandoned
NICHD E-107-2003-0-CA-05 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. CA National Stage 2521120 Abandoned
NIDA E-276-2001-0-PCT-02 Identification And Targeting of Consensus Sites By Which Dynorphin Exerts Its Neurotoxicity Effects Enables Analgesia Without... PCT PCT PCT/US2004/09990 Expired
NCI E-149-2004-0-US-01 Compositions and Methods For Treatment of Inflammatory Disease or Autoimmune Disease With a Modulator of a Chemokine Receptor US 60/558,510 Abandoned
NCI E-268-1997-2-US-07 MUCOSAL CYTOTOXIC T-LYMPHOCYTE RESPONSES US DIV 10/815,340 Abandoned
NCI E-044-2003-0-CA-04 Enhanced HIV-1 Vaccines and Methods for Their Use CA National Stage 2521174 Abandoned
NIAID E-023-2003-0-EP-04 MVA Expressing Modified HIV Envelope, GAG, and POL Genes EP National Stage 04758588.0 Abandoned
NIAID E-023-2003-0-AU-05 MVA Expressing Modified HIV Envelope, GAG, and POL Genes2004226345 AU National Stage 2004226345 Abandoned
NCI E-255-2001-0-US-03 Diagnosis And Treatment of Cancer Involving the Notch Pathway US National Stage 10/479,546 7214488 Abandoned PDF
NCI E-044-2003-0-PCT-02 Enhanced HIV-1 Vaccines and Methods for Their Use PCT PCT PCT/US2004/09617 Expired
NIAID E-023-2003-0-PCT-02 MVA Expressing Modified HIV Envelope, GAG, and POL Genes PCT PCT PCT/US2004/009906 Expired
NIA E-319-2003-0-US-01 "Neural Networks Pattern Recognition For Predicting Pharmacodynamics Using Patient Characteristics" US ORD 10/810,809 Abandoned
NIAID E-023-2003-0-EP-08 MVA Expressing Modified HIV Envelope, GAG, and POL Genes EP DIV 10012381.9 Abandoned
NIAID E-023-2003-0-EP-09 MVA Expressing Modified HIV Envelope, GAG, and POL Genes EP DIV 10012380.1 Abandoned
NIAID E-023-2003-0-EP-10 MVA Expressing Modified HIV Envelope, GAG, and POL Genes EP DIV 10012379.3 Abandoned
NCI E-044-2003-0-EP-05 Enhanced HIV-1 Vaccines and Methods for Their Use EP National Stage 04759021.1 Abandoned
NIAID E-023-2003-0-CA-06 MVA Expressing Modified HIV Envelope, GAG, and POL Genes CA National Stage 2520637 Abandoned
NCI E-030-2004-0-US-01 Analogues of the Schweinfurthins as Potential Anti-Cancer Agents US 60/557,243 Abandoned
NIDDK E-071-2003-0-US-02 A New Method For The Detection Of Genetic Mutations By DNA Mismatch-Targeted Insertion Of A DNA Transposon US ORD 10/809,688 7316903 Abandoned PDF
NCI E-013-2001-0-US-03 REITERATIVELY LAYERED MEDICAL DEVICES AND METHOD OF PREPARING SAME. US National Stage 10/490,991 Abandoned
NINDS E-148-2004-0-US-01 Method To Identify Therapeutic Agents US 60/557,854 Abandoned
NCI E-141-2004-0-US-01 Vanilloid Receptor Agonists US 60/558,003 Abandoned
NINDS E-041-2003-0-PCT-02 In VIVO Brain Elasticity Measurement By Magnetic Resonance Elastography with Vibrator Coil086969 PCT PCT PCT/US2004/09426 Expired
NCI E-069-2004-0-US-01 Formylpeptide Receptor FPR As A Target For Anti-malignant Glioma Therapy US 60/556,058 Abandoned
NIDDK E-148-2008-0-US-01 Compositions And Methods For Inhibiting Mucin-type O-linked Glycosylation US 60/556,673 Abandoned
NINDS E-041-2003-0-CA-04 In VIVO Brain Elasticity Measurement By Magnetic Resonance Elastography with Vibrator Coil CA National Stage 2520566 Abandoned
NINDS E-084-2003-2-PCT-01 Identification, Quantification, and Characterizationof T Cells and T Cell Antigens PCT PCT COMB PCT/US2004/08960 Expired
NINDS E-084-2003-2-CA-03 Identification, Quantification, and Characterizationof T Cells and T Cell Antigens CA National Stage 2520675 Abandoned
NCI E-129-2001-0-US-03 Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. US ORD 10/490,535 7355012 Expired PDF
NCI E-067-1997-0-US-11 COMPOUNDS FORMED BY THE REACTION OF NITRIC OXIDE WITH AMIDINES AND ENAMINES AS PHARMACEUTICAL AGENTS US DIV 10/808,272 6911478 Abandoned PDF
NHLBI E-104-2004-0-US-01 Method For Inducing T-Cell Proliferation US 60/555,898 Abandoned
NCI E-133-2004-0-US-01 "Carbohydrate-Encapsulated Quantum Dots For Biological Imaging" US 60/554,994 Abandoned
NCI E-303-2003-0-US-01 Cellular and Viral Inactivation US 60/555,268 Abandoned
NICHD E-133-1990-0-US-03 GOSSYPOL FOR THE TREATMENT OF CANCER US REISSUE 10/806,088 Abandoned